BOLT vs LH · rev $31.0K vs P/E 23, rev $7.27B
Bolt Biotherapeutics (BOLT) versus Laboratory Corporation of America Holdings (LH) — a side-by-side from cached financials, not a winner call.
Bolt Biotherapeutics (BOLT) is a biotechnology company listed on US.
Laboratory Corporation of America Holdings (LH) is a diagnostics & research company listed on US.
Latest reported BOLT revenue for 2026-06-30 was $31.0K. Net income was -$15.0M. Revenue was up 19.2% from 2026-03-31 to 2026-06-30. BOLT currently screens at market cap $11.3M.
Latest reported LH revenue for 2026-06-30 was $7.27B. Net income was $576.5M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
BOLT currently screens at market cap $11.3M. LH currently screens at market cap $21.07B and trailing P/E 22.8.
Not investment advice. Open the BOLT and LH stock pages for the full models.
Not investment advice.